Financials Optimax Holdings

Equities

End-of-day quote BURSA MALAYSIA Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
0.645 ^MYR	+1.57%		+2.38%	+3.20%

27/03	Optimax Holdings Berhad Appoints Tan Lai Hong as Company Secretary	CI
27/03	Optimax Holdings Berhad Announces the Resignation of Rebecca Kong Say Tsui as Company Secretary, Effective March 27, 2024	CI

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	251.1	348.3	423.9	339.6	350.4	-	-
Enterprise Value (EV) ¹	251.1	348.3	416.9	338.6	340.7	318.2	297
P/E ratio	37.8 x	28.4 x	36 x	27.2 x	23 x	20 x	20.8 x
Yield	-	2.95%	3.06%	1.92%	2.56%	3.26%	3.41%
Capitalization / Revenue	4.33 x	3.92 x	3.92 x	2.98 x	2.78 x	2.49 x	2.41 x
EV / Revenue	4.33 x	3.92 x	3.86 x	2.97 x	2.7 x	2.26 x	2.05 x
EV / EBITDA	14.7 x	13.3 x	12.8 x	10.9 x	9.35 x	7.73 x	7.3 x
EV / FCF	-	-	22.4 x	24.2 x	19.8 x	9.79 x	7.33 x
FCF Yield	-	-	4.46%	4.13%	5.05%	10.2%	13.6%
Price to Book	522 x	-	7.29 x	5.36 x	4.96 x	4.61 x	-
Nbr of stocks (in thousands)	5,40,000	5,40,000	5,40,003	5,43,304	5,43,304	-	-
Reference price ²	0.4650	0.6450	0.7850	0.6250	0.6450	0.6450	0.6450
Announcement Date	25/02/21	24/02/22	28/02/23	28/02/24	-	-	-

¹MYR in Million²MYR

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net sales ¹	62.62	58.02	88.9	108	114	126	141	145.2
EBITDA ¹	-	17.04	26.24	32.45	31.12	36.44	41.14	40.7
EBIT ¹	-	11.09	19.66	24.63	21.24	23	28.62	28.6
Operating Margin	-	19.11%	22.11%	22.79%	18.64%	18.26%	20.3%	19.7%
Earnings before Tax (EBT) ¹	-	9.67	18.59	23.5	20.01	23.54	27.32	27.5
Net income ¹	7.831	5.641	12.3	14.69	12.89	15.5	17.59	17.1
Net margin	12.51%	9.72%	13.83%	13.6%	11.31%	12.31%	12.48%	11.78%
EPS ²	-	0.0123	0.0228	0.0218	0.0230	0.0280	0.0323	0.0310
Free Cash Flow ¹	-	-	-	18.61	13.98	17.2	32.52	40.5
FCF margin	-	-	-	17.23%	12.26%	13.66%	23.07%	27.89%
FCF Conversion (EBITDA)	-	-	-	57.36%	44.91%	47.21%	79.03%	99.51%
FCF Conversion (Net income)	-	-	-	126.7%	108.42%	110.98%	184.85%	236.84%
Dividend per Share ²	-	-	0.0190	0.0240	0.0120	0.0165	0.0210	0.0220
Announcement Date	15/07/20	25/02/21	24/02/22	28/02/23	28/02/24	-	-	-

¹MYR in Million²MYR

Estimates

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Net Debt ¹	-	-	-	-	-	-	-	-
Net Cash position ¹	-	-	-	7.01	1.01	9.7	32.2	53.4
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Free Cash Flow ¹	-	-	-	18.6	14	17.2	32.5	40.5
ROE (net income / shareholders' equity)	-	17.4%	23.9%	26%	21.3%	20.6%	21%	19.5%
ROA (Net income/ Total Assets)	-	8.28%	13.9%	15.2%	11.7%	13.4%	15.7%	11.1%
Assets ¹	-	68.15	88.56	96.85	110.6	116.1	112.4	154.1
Book Value Per Share ²	-	0	-	0.1100	0.1200	0.1300	0.1400	-
Cash Flow per Share	-	-	-	-	-	-	-	-
Capex ¹	-	5.53	-	8.43	11.3	14.9	7.7	6.4
Capex / Sales	-	9.54%	-	7.8%	9.94%	11.83%	5.46%	4.41%
Announcement Date	15/07/20	25/02/21	24/02/22	28/02/23	28/02/24	-	-	-

¹MYR in Million²MYR

Estimates

Trading Rating

Investor Rating

ESG Refinitiv

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.645 MYR

Average target price

0.85 MYR

Spread / Average Target

+31.78%

	1st Jan change	Capi.
OPTIMAX HOLDINGS	+3.20%	73.94M
HCA HEALTHCARE, INC.	+20.68%	85.55B
CVS HEALTH CORPORATION	-29.31%	70.07B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	+9.65%	29.06B
LABORATORY CORPORATION OF AMERICA HOLDINGS	-8.63%	17.51B
FRESENIUS SE & CO. KGAA	+2.14%	17.39B
QUEST DIAGNOSTICS INCORPORATED	+0.39%	15.38B
REDE D'OR SÃO LUIZ S.A.	+6.47%	13.4B
NATERA, INC.	+68.09%	12.87B
FRESENIUS MEDICAL CARE AG	+6.43%	12.77B